These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35908638)

  • 1. Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia.
    Plett C; Klauer LK; Amberger DC; Ugur S; Rabe A; Fischer Z; Deen D; Hirn-Lopez A; Gunsilius C; Werner JO; Schmohl J; Krämer D; Rank A; Schmid C; Schmetzer HM
    Clin Immunol; 2022 Sep; 242():109083. PubMed ID: 35908638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Leukaemia-Derived Dendritic Cells (DC
    Schwepcke C; Klauer LK; Deen D; Amberger DC; Fischer Z; Doraneh-Gard F; Gunsilius C; Hirn-Lopez A; Kroell T; Tischer J; Weinmann M; Werner JO; Rank A; Schmid C; Schmetzer HM
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro.
    Klauer LK; Schutti O; Ugur S; Doraneh-Gard F; Amberger DC; Rogers N; Krämer D; Rank A; Schmid C; Eiz-Vesper B; Schmetzer HM
    Transfus Med Hemother; 2022 Feb; 49(1):44-61. PubMed ID: 35221867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
    Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
    J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture.
    Unterfrauner M; Rejeski HA; Hartz A; Bohlscheid S; Baudrexler T; Feng X; Rackl E; Li L; Rank A; Filippini Velázquez G; Schmid C; Schmohl J; Bojko P; Schmetzer H
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia derived dendritic cell (DC
    Pepeldjiyska E; Li L; Gao J; Seidel CL; Blasi C; Özkaya E; Schmohl J; Kraemer D; Schmid C; Rank A; Schmetzer HM
    Immunobiology; 2022 Jul; 227(4):152237. PubMed ID: 35749805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGE
    Amberger DC; Doraneh-Gard F; Gunsilius C; Weinmann M; Möbius S; Kugler C; Rogers N; Böck C; Ködel U; Werner JO; Krämer D; Eiz-Vesper B; Rank A; Schmid C; Schmetzer HM
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volatile Phases Derived from Serum, DC, or MLC Culture Supernatants to Deduce a VOC-Based Diagnostic Profiling Strategy for Leukemic Diseases.
    Baudrexler T; Boeselt T; Li L; Bohlscheid S; Boas U; Schmid C; Rank A; Schmohl J; Koczulla R; Schmetzer HM
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective and Successful Quantification of Leukemia-Specific Immune Cells in AML Patients' Blood or Culture, Focusing on Intracellular Cytokine and Degranulation Assays.
    Schutti O; Klauer L; Baudrexler T; Burkert F; Schmohl J; Hentrich M; Bojko P; Kraemer D; Rank A; Schmid C; Schmetzer H
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes.
    Rackl E; Li L; Klauer LK; Ugur S; Pepeldjiyska E; Seidel CL; Gunsilius C; Weinmann M; Doraneh-Gard F; Reiter N; Plett C; Amberger DC; Bojko P; Kraemer D; Schmohl J; Rank A; Schmid C; Schmetzer HM
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DC
    Ansprenger C; Amberger DC; Schmetzer HM
    Clin Immunol; 2020 Aug; 217():108467. PubMed ID: 32464186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of AML-blasts to leukemia-derived dendritic cells (DCleu) in 'DC-culture-media' shifts correlations of released chemokines with antileukemic T-cell reactions.
    Merle M; Fischbacher D; Liepert A; Grabrucker C; Kroell T; Kremser A; Dreyssig J; Freudenreich M; Schuster F; Borkhardt A; Kraemer D; Koehne CH; Kolb HJ; Schmid C; Schmetzer HM
    Immunobiology; 2021 May; 226(3):152088. PubMed ID: 33838552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
    Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
    J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characteristics of CD7 positive acute myelogenous leukaemia.
    Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
    Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
    Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thrombopoietin on proliferation of blasts from CD7-positive acute myelogenous leukaemia.
    Tokunaga Y; Miyamoto T; Okamura T; Eto T; Gondo H; Kamimura T; Okamura S; Niho Y
    Br J Haematol; 1998 Sep; 102(5):1232-40. PubMed ID: 9753051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
    Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
    Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage.
    Re F; Arpinati M; Testoni N; Ricci P; Terragna C; Preda P; Ruggeri D; Senese B; Chirumbolo G; Martelli V; Urbini B; Baccarani M; Tura S; Rondelli D
    Exp Hematol; 2002 Feb; 30(2):126-34. PubMed ID: 11823047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.